A detailed history of Putnam Investments LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 52,984 shares of IMVT stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,984
Holding current value
$1.46 Million
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$31.31 - $44.19 $1.66 Million - $2.34 Million
52,984 New
52,984 $2.23 Million
Q1 2021

May 17, 2021

SELL
$13.08 - $49.6 $1.79 Million - $6.79 Million
-136,976 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$36.36 - $52.71 $552,672 - $801,192
15,200 Added 12.48%
136,976 $6.33 Million
Q3 2020

Nov 16, 2020

BUY
$22.61 - $38.9 $238,965 - $411,134
10,569 Added 9.5%
121,776 $4.29 Million
Q2 2020

Aug 14, 2020

BUY
$13.87 - $28.44 $1.54 Million - $3.16 Million
111,207 New
111,207 $2.71 Million

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.